151 related articles for article (PubMed ID: 37557021)
1. Synergestic interplay of uronic acid and sulfation composition of heparan sulfate on molecular recognition to activity.
Bhoge PR; Raigawali R; Mardhekar S; Anand S; Kikkeri R
Carbohydr Res; 2023 Oct; 532():108919. PubMed ID: 37557021
[TBL] [Abstract][Full Text] [Related]
2. Sulfation Code and Conformational Plasticity of l-Iduronic Acid Homo-Oligosaccharides Mimic the Biological Functions of Heparan Sulfate.
Shanthamurthy CD; Gimeno A; Leviatan Ben-Arye S; Kumar NV; Jain P; Padler-Karavani V; Jiménez-Barbero J; Kikkeri R
ACS Chem Biol; 2021 Nov; 16(11):2481-2489. PubMed ID: 34586794
[TBL] [Abstract][Full Text] [Related]
3. Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.
Wu J; Wei J; Chopra P; Boons GJ; Lin C; Zaia J
Anal Chem; 2019 Sep; 91(18):11738-11746. PubMed ID: 31423779
[TBL] [Abstract][Full Text] [Related]
4. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
[TBL] [Abstract][Full Text] [Related]
5. Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.
Wang Z; Xu Y; Yang B; Tiruchinapally G; Sun B; Liu R; Dulaney S; Liu J; Huang X
Chemistry; 2010 Jul; 16(28):8365-75. PubMed ID: 20623566
[TBL] [Abstract][Full Text] [Related]
6. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric method for determining the uronic acid epimerization in heparan sulfate disaccharides generated using nitrous acid.
Gill VL; Wang Q; Shi X; Zaia J
Anal Chem; 2012 Sep; 84(17):7539-46. PubMed ID: 22873817
[TBL] [Abstract][Full Text] [Related]
8. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
9. Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.
Staples GO; Shi X; Zaia J
J Biol Chem; 2010 Jun; 285(24):18336-43. PubMed ID: 20363743
[TBL] [Abstract][Full Text] [Related]
10. Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.
Liang Q; Chopra P; Boons GJ; Sharp JS
Carbohydr Res; 2018 Jul; 465():16-21. PubMed ID: 29920400
[TBL] [Abstract][Full Text] [Related]
11. Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate.
Höök M; Lindahl U; Iverius PH
Biochem J; 1974 Jan; 137(1):33-43. PubMed ID: 4206909
[TBL] [Abstract][Full Text] [Related]
12. De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.
Huang R; Zong C; Venot A; Chiu Y; Zhou D; Boons GJ; Sharp JS
Anal Chem; 2016 May; 88(10):5299-307. PubMed ID: 27087275
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 3-
Dhurandhare VM; Pagadala V; Ferreira A; Muynck L; Liu J
Biochemistry; 2020 Sep; 59(34):3186-3192. PubMed ID: 31608625
[TBL] [Abstract][Full Text] [Related]
14. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
15. Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.
Naimy H; Leymarie N; Zaia J
Biochemistry; 2010 May; 49(17):3743-52. PubMed ID: 20345121
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a Systematic 64-Membered Heparan Sulfate Tetrasaccharide Library.
Baryal KN; Ramadan S; Su G; Huo C; Zhao Y; Liu J; Hsieh-Wilson LC; Huang X
Angew Chem Int Ed Engl; 2023 Jan; 62(1):e202211985. PubMed ID: 36173931
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
Lyon M; Deakin JA; Mizuno K; Nakamura T; Gallagher JT
J Biol Chem; 1994 Apr; 269(15):11216-23. PubMed ID: 8157651
[TBL] [Abstract][Full Text] [Related]
18. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.
Deakin JA; Blaum BS; Gallagher JT; Uhrín D; Lyon M
J Biol Chem; 2009 Mar; 284(10):6311-21. PubMed ID: 19114710
[TBL] [Abstract][Full Text] [Related]
19. Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties.
Mahalingam Y; Gallagher JT; Couchman JR
J Biol Chem; 2007 Feb; 282(5):3221-30. PubMed ID: 17130131
[TBL] [Abstract][Full Text] [Related]
20. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
